BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016;8:339ra71. [PMID: 27194729 DOI: 10.1126/scitranslmed.aaf2311] [Cited by in Crossref: 248] [Cited by in F6Publishing: 241] [Article Influence: 49.6] [Reference Citation Analysis]
Number Citing Articles
1 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
2 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
3 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
4 Nabarrete JM, Pereira AZ, Garófolo A, Seber A, Venancio AM, Grecco CES, Bonfim CMS, Nakamura CH, Fernandes D, Campos DJ, Oliveira FLC, Cousseiro FK, Rossi FFP, Gurmini J, Viani KHC, Guterres LF, Mantovani LFAL, Darrigo Junior LG, Albuquerque MIBPE, Brumatti M, Neves MA, Duran N, Villela NC, Zecchin VG, Fernandes JF. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents. Einstein (Sao Paulo) 2021;19:eAE5254. [PMID: 34909973 DOI: 10.31744/einstein_journal/2021AE5254] [Reference Citation Analysis]
5 Han L, Zhang H, Chen S, Zhou L, Li Y, Zhao K, Huang F, Fan Z, Xuan L, Zhang X, Dai M, Lin Q, Jiang Z, Peng J, Jin H, Liu Q. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2019;25:1944-55. [PMID: 31299215 DOI: 10.1016/j.bbmt.2019.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
6 Chanderraj R, Brown CA, Hinkle K, Falkowski N, Woods RJ, Dickson RP. The bacterial density of clinical rectal swabs is highly variable, correlates with sequencing contamination, and predicts patient risk of extraintestinal infection. Microbiome 2022;10:2. [PMID: 34991717 DOI: 10.1186/s40168-021-01190-y] [Reference Citation Analysis]
7 Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 2017;23:820-9. [PMID: 28192251 DOI: 10.1016/j.bbmt.2017.02.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 15.6] [Reference Citation Analysis]
8 Simms-Waldrip TR, Koh AY. Food for Gut: Microbiota Fuels Immune Reconstitution after BMT. Cell Host Microbe 2018;23:423-4. [PMID: 29649435 DOI: 10.1016/j.chom.2018.03.015] [Reference Citation Analysis]
9 Hanks CR, Slain D, Kanate AS, Wen S, Cumpston A. Impact of anti-anaerobic antibiotic activity on graft-versus-host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling. Transpl Infect Dis 2021;:e13676. [PMID: 34165853 DOI: 10.1111/tid.13676] [Reference Citation Analysis]
10 Scordo M, Shah GL, Peled JU, Preston EV, Buchan ML, Epstein JB, Barasch A, Giralt SA. Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2018;24:425-32. [PMID: 29051023 DOI: 10.1016/j.bbmt.2017.10.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
11 Jasiński M, Biliński J, Basak GW. The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias. Front Oncol 2021;11:741376. [PMID: 34660303 DOI: 10.3389/fonc.2021.741376] [Reference Citation Analysis]
12 Zhong S, Zeng J, Deng Z, Jiang L, Zhang B, Yang K, Wang W, Zhang T. Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report. Ital J Pediatr 2019;45:116. [PMID: 31462301 DOI: 10.1186/s13052-019-0708-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Meedt E, Hiergeist A, Gessner A, Dettmer K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Weber D. Prolonged suppression of butyrate producing bacteria is associated with acute gastrointestinal graft-versus-host disease and transplant related mortality after allogeneic stem cell transplantation. Clin Infect Dis 2021:ciab500. [PMID: 34043764 DOI: 10.1093/cid/ciab500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Toubai T, Fujiwara H, Rossi C, Riwes M, Tamaki H, Zajac C, Liu C, Mathew AV, Byun J, Oravecz-Wilson K, Matsuda I, Sun Y, Peltier D, Wu J, Chen J, Seregin S, Henig I, Kim S, Brabbs S, Pennathur S, Chen G, Reddy P. Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. Nat Microbiol 2019;4:800-12. [PMID: 30858572 DOI: 10.1038/s41564-019-0373-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
15 Camargo JF, Mendoza MA, Lin R, Moroz IV, Anderson AD, Morris MI, Natori Y, Natori A, Raja M, Lekakis L, Beitinjaneh A, Jimenez A, Goodman M, Wang T, Komanduri KV, Pereira D. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Transpl Infect Dis 2021;:e13625. [PMID: 33896088 DOI: 10.1111/tid.13625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Riwes M, Reddy P. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 2020;57:1-6. [DOI: 10.1053/j.seminhematol.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Routy B, Letendre C, Enot D, Chénard-Poirier M, Mehraj V, Séguin NC, Guenda K, Gagnon K, Woerther PL, Ghez D, Lachance S. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology 2017;6:e1258506. [PMID: 28197380 DOI: 10.1080/2162402X.2016.1258506] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
18 Malard F, Mohty M. Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do? Br J Haematol 2020;188:351-3. [PMID: 31524291 DOI: 10.1111/bjh.16204] [Reference Citation Analysis]
19 Fredricks DN. The gut microbiota and graft-versus-host disease. J Clin Invest 2019;129:1808-17. [PMID: 31042160 DOI: 10.1172/JCI125797] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 11.3] [Reference Citation Analysis]
20 Hong Y, Liu L, Chang Y, Wang Y, Zhang X, Xu L, Huang X, Zhao X. CD8+CD161hi T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplant 2020;55:1652-4. [PMID: 32123289 DOI: 10.1038/s41409-020-0842-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Khuat LT, Dave M, Murphy WJ. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation. Gut Microbes 2021;13:1966262. [PMID: 34455917 DOI: 10.1080/19490976.2021.1966262] [Reference Citation Analysis]
22 Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y, Miyamoto T, Hata J, Ninomiya T, Kashiwazaki H, Yamashita Y. Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation. PLoS Pathog 2020;16:e1008348. [PMID: 32150591 DOI: 10.1371/journal.ppat.1008348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 2018;15:382-96. [PMID: 29636538 DOI: 10.1038/s41571-018-0006-2] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 55.7] [Reference Citation Analysis]
24 Schubert ML, Rohrbach R, Schmitt M, Stein-Thoeringer CK. The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy. Front Immunol 2021;12:670286. [PMID: 34135898 DOI: 10.3389/fimmu.2021.670286] [Reference Citation Analysis]
25 Fredricks DN. The gut microbiota and graft-versus-host disease. Journal of Clinical Investigation 2019;129:1808-17. [DOI: 10.1172/jci125797] [Reference Citation Analysis]
26 Zeiser R. Biology-driven developments in the therapy of acute graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2018;2018:236-41. [PMID: 30504316 DOI: 10.1182/asheducation-2018.1.236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Koyama M, Hill GR. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease. Blood. 2019;134:2139-2148. [PMID: 31697827 DOI: 10.1182/blood.2019000823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
28 Rashidi A, Kaiser T, Holtan SG, Weisdorf DJ, Khoruts A, Staley C. Pre-transplant recovery of microbiome diversity without recovery of the original microbiome. Bone Marrow Transplant. 2019;54:1115-1117. [PMID: 30498199 DOI: 10.1038/s41409-018-0414-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
29 Yoshioka K, Kakihana K, Doki N, Ohashi K. Gut microbiota and acute graft-versus-host disease. Pharmacol Res 2017;122:90-5. [PMID: 28576475 DOI: 10.1016/j.phrs.2017.05.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
30 Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current Concepts and Advances in Graft-Versus-Host Disease Immunology. Annu Rev Immunol 2021;39:19-49. [PMID: 33428454 DOI: 10.1146/annurev-immunol-102119-073227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Golob JL, DeMeules MM, Loeffelholz T, Quinn ZZ, Dame MK, Silvestri SS, Wu MC, Schmidt TM, Fiedler TL, Hoostal MJ, Mielcarek M, Spence J, Pergam SA, Fredricks DN. Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD. Blood Adv 2019;3:2866-9. [PMID: 31585950 DOI: 10.1182/bloodadvances.2019000362] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
32 Hülsdünker J, Thomas OS, Haring E, Unger S, Gonzalo Núñez N, Tugues S, Gao Z, Duquesne S, Cywes-Bentley C, Oyardi O, Kirschnek S, Schmitt-Graeff A, Pabst O, Koenecke C, Duyster J, Apostolova P, Blaser MJ, Becher B, Pier GB, Häcker G, Zeiser R. Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity. Proc Natl Acad Sci U S A 2019;116:20700-6. [PMID: 31527267 DOI: 10.1073/pnas.1908549116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
33 Ball JA, Clear A, Aries J, Charrot S, Besley C, Mee M, Stagg A, Lindsay JO, Cavenagh J, Calaminci M, Gribben JG, Davies J. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD. Blood 2021;137:702-17. [PMID: 32905596 DOI: 10.1182/blood.2020005170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wu SR, Reddy P. Tissue tolerance: a distinct concept to control acute GVHD severity. Blood 2017;129:1747-52. [PMID: 28153825 DOI: 10.1182/blood-2016-09-740431] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
35 Roberts MB, Fishman JA. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". Clin Infect Dis 2020:ciaa1189. [PMID: 32803228 DOI: 10.1093/cid/ciaa1189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
36 Yang L, Bajinka O, Jarju PO, Tan Y, Taal AM, Ozdemir G. The varying effects of antibiotics on gut microbiota. AMB Express 2021;11:116. [PMID: 34398323 DOI: 10.1186/s13568-021-01274-w] [Reference Citation Analysis]
37 Lyu MN, Han MZ. [Advances in intestinal microbiota and graft versus host disease]. Zhonghua Xue Ye Xue Za Zhi 2017;38:1085-8. [PMID: 29365409 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.019] [Reference Citation Analysis]
38 Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, Dettmer K, Weber M, Wolff D, Hahn J, Pamer EG, Herr W, Gessner A, Oefner PJ, van den Brink MRM, Holler E. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 2017;23:845-52. [PMID: 28232086 DOI: 10.1016/j.bbmt.2017.02.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 23.6] [Reference Citation Analysis]
39 Fischer JC, Poeck H. Targeting RIG-I or STING promotes epithelial regeneration. Oncotarget 2017;8:114418-9. [PMID: 29383086 DOI: 10.18632/oncotarget.22994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Ferrara JLM, Chaudhry MS. GVHD: biology matters. Hematology Am Soc Hematol Educ Program 2018;2018:221-7. [PMID: 30504314 DOI: 10.1182/asheducation-2018.1.221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zeng D. Newly found arsons ignite the fire of gut GVHD. J Clin Invest 2018;128:897-9. [PMID: 29376890 DOI: 10.1172/JCI98685] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L, Chifiriuc MC. Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer. Front Immunol 2018;9:1830. [PMID: 30158926 DOI: 10.3389/fimmu.2018.01830] [Cited by in Crossref: 148] [Cited by in F6Publishing: 134] [Article Influence: 37.0] [Reference Citation Analysis]
43 Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33:570-580. [PMID: 29634945 DOI: 10.1016/j.ccell.2018.03.015] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 123.7] [Reference Citation Analysis]
44 Ganetsky A, Han JH, Hughes ME, Babushok DV, Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Mangan JK, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients. Clin Infect Dis 2019;68:2003-9. [PMID: 30256954 DOI: 10.1093/cid/ciy822] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
45 van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, Heubel-Moenen FCJI, Nur E, Zeerleder SS, Nieuwdorp M, Blom B, Hazenberg MD. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med 2020;12:eaaz8926. [PMID: 32801142 DOI: 10.1126/scitranslmed.aaz8926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
46 Biliński J, Jasiński M, Basak GW. The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease. Biomedicines 2022;10:837. [DOI: 10.3390/biomedicines10040837] [Reference Citation Analysis]
47 Song A, Shen N, Gan C, Luo C, Luo C, Wang J, Cao Q, Chen J. Exploration of the relationship between intestinal flora changes and gut acute graft-versus-host disease after hematopoietic stem cell transplantation. Transl Pediatr 2021;10:283-95. [PMID: 33708514 DOI: 10.21037/tp-20-208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Yoshifuji K, Inamoto K, Kiridoshi Y, Takeshita K, Sasajima S, Shiraishi Y, Yamashita Y, Nisaka Y, Ogura Y, Takeuchi R, Toya T, Igarashi A, Najima Y, Doki N, Kobayashi T, Ohashi K, Suda W, Atarashi K, Shiota A, Hattori M, Honda K, Kakihana K. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv 2020;4:4607-17. [PMID: 32991720 DOI: 10.1182/bloodadvances.2020002604] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
49 Rashidi A, Kaiser T, Shields-Cutler R, Graiziger C, Holtan SG, Rehman TU, Wasko J, Weisdorf DJ, Dunny G, Khoruts A, Staley C. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia. Sci Rep 2019;9:6083. [PMID: 30988420 DOI: 10.1038/s41598-019-42652-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
50 Hueso T, Ekpe K, Mayeur C, Gatse A, Joncquel-Chevallier Curt M, Gricourt G, Rodriguez C, Burdet C, Ulmann G, Neut C, Amini SE, Lepage P, Raynard B, Willekens C, Micol JB, De Botton S, Yakoub-Agha I, Gottrand F, Desseyn JL, Thomas M, Woerther PL, Seguy D. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening. Gut Microbes 2020;12:1800897. [PMID: 32893715 DOI: 10.1080/19490976.2020.1800897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
51 Schwabkey ZI, Jenq RR. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. Annu Rev Med 2020;71:137-48. [PMID: 31986084 DOI: 10.1146/annurev-med-052918-122440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
52 Michonneau D, Latis E, Curis E, Dubouchet L, Ramamoorthy S, Ingram B, de Latour RP, Robin M, de Fontbrune FS, Chevret S, Rogge L, Socié G. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat Commun 2019;10:5695. [PMID: 31836702 DOI: 10.1038/s41467-019-13498-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
53 Ferrara JL, Smith CM, Sheets J, Reddy P, Serody JS. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest 2017;127:2441-51. [PMID: 28581444 DOI: 10.1172/JCI90592] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
54 Li X, Lin Y, Li X, Xu X, Zhao Y, Xu L, Gao Y, Li Y, Tan Y, Qian P, Huang H. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome. EBioMedicine 2020;61:103048. [PMID: 33039712 DOI: 10.1016/j.ebiom.2020.103048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Yu J, Sun H, Cao W, Han L, Song Y, Wan D, Jiang Z. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Exp Hematol Oncol 2020;9:35. [PMID: 33292670 DOI: 10.1186/s40164-020-00194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Lu Y, Meng R, Wang X, Xu Y, Tang Y, Wu J, Xue Q, Yu S, Duan M, Shan D, Wang Q, Wang H, Billiar TR, Xiao X, Chen F, Lu B. Caspase-11 signaling enhances graft-versus-host disease. Nat Commun 2019;10:4044. [PMID: 31492850 DOI: 10.1038/s41467-019-11895-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
57 Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, Giannotti F, Dulery R, Joly AC, Baylatry MT, Kossmann MJ, Tankovic J, Beaugerie L, Sokol H, Mohty M. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Haematologica 2019;104:1682-8. [PMID: 30733264 DOI: 10.3324/haematol.2018.198549] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 16.7] [Reference Citation Analysis]
58 Noor F, Kaysen A, Wilmes P, Schneider JG. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials. J Innate Immun 2019;11:405-15. [PMID: 30286447 DOI: 10.1159/000492943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
59 Mancini N, Greco R, Pasciuta R, Barbanti MC, Pini G, Morrow OB, Morelli M, Vago L, Clementi N, Giglio F, Lupo Stanghellini MT, Forcina A, Infurnari L, Marktel S, Assanelli A, Carrabba M, Bernardi M, Corti C, Burioni R, Peccatori J, Sormani MP, Banfi G, Ciceri F, Clementi M. Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients. Open Forum Infect Dis 2017;4:ofx215. [PMID: 29226172 DOI: 10.1093/ofid/ofx215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
60 Anand S, Thomas S, Hyslop T, Adcock J, Corbet K, Gasparetto C, Lopez R, Long GD, Morris AK, Rizzieri DA, Sullivan KM, Sung AD, Sarantopoulos S, Chao NJ, Horwitz ME. Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization. Biol Blood Marrow Transplant 2017;23:1151-7. [PMID: 28392378 DOI: 10.1016/j.bbmt.2017.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
61 Papanicolas LE, Warner M, Wesselingh SL, Rogers GB. Protect commensal gut bacteria to improve antimicrobial stewardship. Clin Microbiol Infect 2020;26:814-5. [PMID: 32234452 DOI: 10.1016/j.cmi.2020.03.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
63 Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation. Clin Transplant 2018;32:e13361. [PMID: 30054935 DOI: 10.1111/ctr.13361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
64 Spindelboeck W, Schulz E, Uhl B, Kashofer K, Aigelsreiter A, Zinke-Cerwenka W, Mulabecirovic A, Kump PK, Halwachs B, Gorkiewicz G, Sill H, Greinix H, Högenauer C, Neumeister P. Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica 2017;102:e210-3. [PMID: 28154090 DOI: 10.3324/haematol.2016.154351] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
65 Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ. Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transplant 2017;52:1091-106. [PMID: 28346417 DOI: 10.1038/bmt.2017.14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
66 Elgarten CW, Arnold SD, Li Y, Huang YV, Riches ML, Gerber JS, Aplenc R, Saber W, Fisher BT. Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Infect Control Hosp Epidemiol 2018;39:797-805. [PMID: 29734957 DOI: 10.1017/ice.2018.96] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
67 Bajic D, Niemann A, Hillmer A, Mejias-luque R, Bluemel S, Docampo M, Funk MC, Tonin E, Boutros M, Schnabl B, Busch DH, Miki T, Schmid RM, van den Brink MRM, Gerhard M, Stein-thoeringer CK. Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice. Journal of Crohn's and Colitis 2020;14:1462-72. [DOI: 10.1093/ecco-jcc/jjaa065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
68 Bowerman KL, Varelias A, Lachner N, Kuns RD, Hill GR, Hugenholtz P. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice. Gut Microbes 2020;11:754-70. [PMID: 31928131 DOI: 10.1080/19490976.2019.1705729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
69 Wang Y. Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6. Bioengineered 2021;12:4500-7. [PMID: 34308757 DOI: 10.1080/21655979.2021.1955549] [Reference Citation Analysis]
70 Rashidi A, Shanley R, Holtan SG, MacMillan ML, Blazar BR, Khoruts A, Weisdorf DJ. Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 2018;24:2190-6. [PMID: 30454871 DOI: 10.1016/j.bbmt.2018.06.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y. Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1028-33. [DOI: 10.1016/j.bbmt.2020.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
72 Khoruts A, Hippen KL, Lemire AM, Holtan SG, Knights D, Young JH. Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. Transl Res 2017;179:116-25. [PMID: 27513211 DOI: 10.1016/j.trsl.2016.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
73 Farhadfar N, Gharaibeh RZ, Lyon D, Whitlock JA, Murthy HS, Weaver MT, Wang GP, Jobin C, Wingard JR, Kelly DL. Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease. Hematol Oncol Stem Cell Ther 2021;14:263-5. [PMID: 33785388 DOI: 10.1016/j.hemonc.2021.03.004] [Reference Citation Analysis]
74 Luke JJ, Pal SK. Further evidence to support judicious use of antibiotics in patients with cancer. Ann Oncol 2018;29:1349-51. [PMID: 29688263 DOI: 10.1093/annonc/mdy153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
75 Johnston R. Engaging Cell and Gene Therapists in HIV Cure. Hum Gene Ther 2021;32:17-20. [PMID: 32962421 DOI: 10.1089/hum.2020.236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Köhler N, Zeiser R. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Front Immunol 2018;9:3179. [PMID: 30705680 DOI: 10.3389/fimmu.2018.03179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
78 [DOI: 10.1101/855486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Hueso T, Coiteux V, Joncquel Chevalier Curt M, Labreuche J, Jouault T, Yakoub-Agha I, Seguy D. Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017;23:913-921. [PMID: 28263922 DOI: 10.1016/j.bbmt.2017.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
80 Kornblit B, Müller K. Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:499-505. [PMID: 27941769 DOI: 10.1038/bmt.2016.263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
81 Fujiwara H. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2021;12:703298. [PMID: 34512627 DOI: 10.3389/fimmu.2021.703298] [Reference Citation Analysis]
82 Bouazzaoui A, Huber E, Dan A, Al-Allaf FA, Pfirstinger J, Sprotte G, Köstler J, Hiergeist A, Gessner A, Herr W, Holler E. Reduction of aGVHD using chicken antibodies directed against intestinal pathogens in a murine model. Blood 2017;129:1052-5. [PMID: 28011676 DOI: 10.1182/blood-2016-06-722538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
83 Pouncey AL, Scott AJ, Alexander JL, Marchesi J, Kinross J. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment. Ecancermedicalscience. 2018;12:868. [PMID: 30263059 DOI: 10.3332/ecancer.2018.868] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
84 Hippen KL, Aguilar EG, Rhee SY, Bolivar-Wagers S, Blazar BR. Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease. Trends Immunol 2020;41:77-91. [PMID: 31791718 DOI: 10.1016/j.it.2019.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
85 Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, Pinedo R, Tsakmaklis A, Littmann ER, Pastore A, Taur Y, Monette S, Arcila ME, Pickard AJ, Maloy M, Wright RJ, Amoretti LA, Fontana E, Pham D, Jamal MA, Weber D, Sung AD, Hashimoto D, Scheid C, Xavier JB, Messina JA, Romero K, Lew M, Bush A, Bohannon L, Hayasaka K, Hasegawa Y, Vehreschild MJGT, Cross JR, Ponce DM, Perales MA, Giralt SA, Jenq RR, Teshima T, Holler E, Chao NJ, Pamer EG, Peled JU, van den Brink MRM. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 2019;366:1143-9. [PMID: 31780560 DOI: 10.1126/science.aax3760] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 39.0] [Reference Citation Analysis]
86 Gjærde LK, Schmidt M, Sengeløv H. Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease. Bone Marrow Transplant 2018;53:1061-4. [PMID: 29491465 DOI: 10.1038/s41409-018-0131-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
87 Minnie SA, Hill GR. Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy? Front Immunol 2021;12:651288. [PMID: 33777050 DOI: 10.3389/fimmu.2021.651288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Khuat LT, Le CT, Pai CS, Shields-Cutler RR, Holtan SG, Rashidi A, Parker SL, Knights D, Luna JI, Dunai C, Wang Z, Sturgill IR, Stoffel KM, Merleev AA, More SK, Maverakis E, Raybould HE, Chen M, Canter RJ, Monjazeb AM, Dave M, Ferrara JLM, Levine JE, Longo DL, Abedi M, Blazar BR, Murphy WJ. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation. Sci Transl Med 2020;12:eaay7713. [PMID: 33239390 DOI: 10.1126/scitranslmed.aay7713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, Núñez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun 2018;9:3674. [PMID: 30201970 DOI: 10.1038/s41467-018-06048-w] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
90 Ramakrishna C, Mendonca S, Ruegger PM, Kim JH, Borneman J, Cantin EM. Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis. PLoS One 2020;15:e0237189. [PMID: 32760124 DOI: 10.1371/journal.pone.0237189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 McDaniel Mims B, Enriquez J, Pires Dos Santos A, Jones-Hall Y, Dowd S, Furr KL, Grisham MB. Antibiotic administration exacerbates acute graft vs. host disease-induced bone marrow and spleen damage in lymphopenic mice. PLoS One 2021;16:e0254845. [PMID: 34358240 DOI: 10.1371/journal.pone.0254845] [Reference Citation Analysis]
92 de Molla VC, Heidrich V, Bruno JS, Knebel FH, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Camargo AA, Fregnani ER, Arrais-Rodrigues C. Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation. Sci Rep 2021;11:17552. [PMID: 34475459 DOI: 10.1038/s41598-021-96939-8] [Reference Citation Analysis]
93 Han L, Jin H, Zhou L, Zhang X, Fan Z, Dai M, Lin Q, Huang F, Xuan L, Zhang H, Liu Q. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients. Front Immunol 2018;9:669. [PMID: 29740427 DOI: 10.3389/fimmu.2018.00669] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
94 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood. 2016;128:2395-2402. [PMID: 27856471 DOI: 10.1182/blood-2016-06-716738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
95 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Reference Citation Analysis]
96 Perobelli SM, Silva TG, Bonomo A. Neutrophils Plasticity: The Regulatory Interface in Various Pathological Conditions. In: Khajah MA, editor. Role of Neutrophils in Disease Pathogenesis. InTech; 2017. [DOI: 10.5772/68130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
97 Galloway-Peña JR, Jenq RR, Shelburne SA. Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient? Clin Cancer Res 2017;23:3263-8. [PMID: 28298544 DOI: 10.1158/1078-0432.CCR-16-3173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
98 Ogimi C, Krantz EM, Golob JL, Waghmare A, Liu C, Leisenring WM, Woodard CR, Marquis S, Kuypers JM, Jerome KR, Pergam SA, Fredricks DN, Sorror ML, Englund JA, Boeckh M. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2293-301. [PMID: 29777867 DOI: 10.1016/j.bbmt.2018.05.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
99 Wallace G, Rosen N, Towbin AJ, Jodele S, Myers KC, Davies SM, Flannery A, Gurria JP. Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough. J Pediatr Surg 2021:S0022-3468(21)00002-6. [PMID: 33455803 DOI: 10.1016/j.jpedsurg.2020.12.020] [Reference Citation Analysis]
100 Maurer AK, Li S, Hunter BD, Luk SO, O'Donnell SE, Dey BR, El-Jawahri A, Frigault MJ, McAfee S, O'Donnell PV, Spitzer TR, Chen YB, DeFilipp Z. Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2020;55:2319-21. [PMID: 32457426 DOI: 10.1038/s41409-020-0923-4] [Reference Citation Analysis]
101 Antin JH. Relationship Between Intestinal Bacteria and the Anticancer Effect of Hematopoietic Stem-Cell Transplantation. J Clin Oncol 2017;35:1636-7. [PMID: 28296583 DOI: 10.1200/JCO.2017.72.2603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Papanicolas LE, Sims SK, Taylor SL, Miller SJ, Karapetis CS, Wesselingh SL, Gordon DL, Rogers GB. Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome. BMC Cancer 2021;21:591. [PMID: 34022842 DOI: 10.1186/s12885-021-08296-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Fiorenza S, Turtle CJ. Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. Immunometabolism 2021;3:e210004. [PMID: 33552594 DOI: 10.20900/immunometab20210004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
104 Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv 2020;4:5797-809. [PMID: 33232475 DOI: 10.1182/bloodadvances.2020002677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
105 Ara T, Hashimoto D, Hayase E, Noizat C, Kikuchi R, Hasegawa Y, Matsuda K, Ono S, Matsuno Y, Ebata K, Ogasawara R, Takahashi S, Ohigashi H, Yokoyama E, Matsuo K, Sugita J, Onozawa M, Okumura R, Takeda K, Teshima T. Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8. Sci Transl Med 2020;12:eaaw0720. [PMID: 32611682 DOI: 10.1126/scitranslmed.aaw0720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
106 Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med 2018;10:eaap9489. [PMID: 30257956 DOI: 10.1126/scitranslmed.aap9489] [Cited by in Crossref: 138] [Cited by in F6Publishing: 128] [Article Influence: 46.0] [Reference Citation Analysis]
107 Golob JL, Pergam SA, Srinivasan S, Fiedler TL, Liu C, Garcia K, Mielcarek M, Ko D, Aker S, Marquis S, Loeffelholz T, Plantinga A, Wu MC, Celustka K, Morrison A, Woodfield M, Fredricks DN. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation. Clin Infect Dis 2017;65:1984-91. [PMID: 29020185 DOI: 10.1093/cid/cix699] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 18.8] [Reference Citation Analysis]
108 D'Amico F, Soverini M, Zama D, Consolandi C, Severgnini M, Prete A, Pession A, Barone M, Turroni S, Biagi E, Brigidi P, Masetti R, Rampelli S, Candela M. Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation. Sci Rep 2019;9:5649. [PMID: 30948795 DOI: 10.1038/s41598-019-42222-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
109 Liu C, Frank DN, Horch M, Chau S, Ir D, Horch EA, Tretina K, van Besien K, Lozupone CA, Nguyen VH. Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone Marrow Transplant 2017;52:1643-50. [PMID: 28967895 DOI: 10.1038/bmt.2017.200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
110 Kanangat S, Skaljic I. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing. Hum Immunol 2021:S0198-8859(21)00183-X. [PMID: 34364710 DOI: 10.1016/j.humimm.2021.07.009] [Reference Citation Analysis]
111 Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest 2018;128:4970-9. [PMID: 30106382 DOI: 10.1172/JCI99261] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
112 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
113 Fätkenheuer G, Jung N, Kern WV, Fölsch UR, Salzberger B. [Infectious diseases - a specialty of internal medicine]. Internist (Berl) 2018;59:334-40. [PMID: 29459991 DOI: 10.1007/s00108-018-0387-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
115 Catchpoole EM, Thirunavukarasu CE, Varelias A, Schlebusch S, Olver S, Zomerdijk N, Osland E, Kennedy GA, Tey S, Hill GR, Markey KA. Early Blood Stream Infections after BMT are Associated with Cytokine Dysregulation and Poor Overall Survival. Biology of Blood and Marrow Transplantation 2018;24:1360-6. [DOI: 10.1016/j.bbmt.2018.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
116 Ciernikova S, Kasperova B, Drgona L, Smolkova B, Stevurkova V, Mego M. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation. Blood Rev 2021;48:100790. [PMID: 33573867 DOI: 10.1016/j.blre.2020.100790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Kapandji N, Azoulay E, Zafrani L. Recent advances in neutropenic enterocolitis: Insights into the role of gut microbiota. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100944] [Reference Citation Analysis]
118 Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med 2017;9:21. [PMID: 28245856 DOI: 10.1186/s13073-017-0409-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
119 Nishi K, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A. Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 2018;24:2178-83. [PMID: 30417828 DOI: 10.1016/j.bbmt.2018.06.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
120 Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ. Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. Br J Haematol 2018;182:887-94. [PMID: 30004111 DOI: 10.1111/bjh.15492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
121 Wardill HR, van der Aa SAR, da Silva Ferreira AR, Havinga R, Tissing WJE, Harmsen HJM. Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation. Eur J Cancer 2021;153:27-39. [PMID: 34130227 DOI: 10.1016/j.ejca.2021.05.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Song Q, Wang X, Wu X, Kang TH, Qin H, Zhao D, Jenq RR, van den Brink MRM, Riggs AD, Martin PJ, Chen YZ, Zeng D. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice. Nat Commun 2021;12:805. [PMID: 33547295 DOI: 10.1038/s41467-021-21133-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
123 Dougé A, Bay JO, Ravinet A, Scanzi J. [Intestinal microbiota and allogeneic stem cell transplantation]. Bull Cancer 2020;107:72-83. [PMID: 31582175 DOI: 10.1016/j.bulcan.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
124 Fessler JL, Gajewski TF. The Microbiota: A New Variable Impacting Cancer Treatment Outcomes. Clin Cancer Res 2017;23:3229-31. [PMID: 28446507 DOI: 10.1158/1078-0432.CCR-17-0864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
125 Li S, Sun Y, Diao L, Wang X. Distance-Based Analysis with Quantile Regression Models. Stat Biosci 2021;13:291-312. [DOI: 10.1007/s12561-021-09306-6] [Reference Citation Analysis]
126 Kaundal S, Jandial A, Singh H, Chopra M, Kasudhan KS, Khaire N, Khadwal A, Prakash G, Jain A, Suri V, Patil A, Arora A, Sharma V, Ray P, Malhotra P, Lad DP. Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomes. Transpl Infect Dis 2021;23:e13717. [PMID: 34431187 DOI: 10.1111/tid.13717] [Reference Citation Analysis]
127 Baghai Arassi M, Zeller G, Karcher N, Zimmermann M, Toenshoff B. The gut microbiome in solid organ transplantation. Pediatr Transplant 2020;24:e13866. [PMID: 32997434 DOI: 10.1111/petr.13866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
128 Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, Uhlemann AC, Lightdale CJ, Abrams JA. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019;28:1687-1693. [PMID: 31466948 DOI: 10.1158/1055-9965.epi-19-0008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
129 Rashidi A, Khoruts A, Weisdorf DJ. Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics. Biology of Blood and Marrow Transplantation 2017;23:1038-9. [DOI: 10.1016/j.bbmt.2017.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
130 Ingham AC, Kielsen K, Cilieborg MS, Lund O, Holmes S, Aarestrup FM, Müller KG, Pamp SJ. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome 2019;7:131. [PMID: 31519210 DOI: 10.1186/s40168-019-0745-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
131 Singh RP, Bashir H, Kumar R. Emerging role of microbiota in immunomodulation and cancer immunotherapy. Semin Cancer Biol 2021;70:37-52. [PMID: 32580024 DOI: 10.1016/j.semcancer.2020.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P, Clurman A, Dwomoh E, Armijo G, Gomes ALC, Littmann ER, Schluter J, Fontana E, Taur Y, Park JH, Palomba ML, Halton E, Ruiz J, Jain T, Pennisi M, Afuye AO, Perales MA, Freyer CW, Garfall A, Gier S, Nasta S, Landsburg D, Gerson J, Svoboda J, Cross J, Chong EA, Giralt S, Gill SI, Riviere I, Porter DL, Schuster SJ, Sadelain M, Frey N, Brentjens RJ, June CH, Pamer EG, Peled JU, Facciabene A, van den Brink MRM, Ruella M. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med 2022. [PMID: 35288695 DOI: 10.1038/s41591-022-01702-9] [Reference Citation Analysis]
133 Kouidhi S, Souai N, Zidi O, Mosbah A, Lakhal A, Ben Othmane T, Belloumi D, Ben Ayed F, Asimakis E, Stathopoulou P, Cherif A, Tsiamis G. High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients. Microorganisms 2021;9:1845. [PMID: 34576740 DOI: 10.3390/microorganisms9091845] [Reference Citation Analysis]
134 Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer 2020;126:3629-37. [PMID: 32533793 DOI: 10.1002/cncr.33030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Yang B, Zhang X, Gong H, Huang Y, Wang C, Liu H, Dong C, Ma S, Wu X, Wu D. High stearic acid diet modulates gut microbiota and aggravates acute graft-versus-host disease. Signal Transduct Target Ther 2021;6:277. [PMID: 34294684 DOI: 10.1038/s41392-021-00600-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation). Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol 2016;95:1435-55. [PMID: 27339055 DOI: 10.1007/s00277-016-2711-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 80] [Article Influence: 17.7] [Reference Citation Analysis]
137 Bejanyan N, Rashidi A. A gut-graft axis mediated by microbiota. Blood 2022;139:2727-8. [PMID: 35511188 DOI: 10.1182/blood.2021015338] [Reference Citation Analysis]
138 Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood 2020;136:429-40. [PMID: 32526035 DOI: 10.1182/blood.2019000953] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
139 Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol 2020;188:438-49. [PMID: 31566729 DOI: 10.1111/bjh.16205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
140 Socié G, Kean LS, Zeiser R, Blazar BR. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease. J Clin Invest 2021;131:149296. [PMID: 34101618 DOI: 10.1172/JCI149296] [Reference Citation Analysis]
141 Spindelboeck W, Halwachs B, Bayer N, Huber-Krassnitzer B, Schulz E, Uhl B, Gaksch L, Hatzl S, Bachmayr V, Kleissl L, Kump P, Deutsch A, Stary G, Greinix H, Gorkiewicz G, Högenauer C, Neumeister P. Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study. Ther Adv Hematol 2021;12:20406207211058333. [PMID: 34987741 DOI: 10.1177/20406207211058333] [Reference Citation Analysis]
142 Ghanem S, Kim CJ, Dutta D, Salifu M, Lim SH. Antimicrobial therapy during cancer treatment: Beyond antibacterial effects. J Intern Med 2021;290:40-56. [PMID: 33372309 DOI: 10.1111/joim.13238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Mohamed FA, Thangavelu G, Rhee SY, Sage PT, O'Connor RS, Rathmell JC, Blazar BR. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. Front Immunol 2021;12:757836. [PMID: 34712243 DOI: 10.3389/fimmu.2021.757836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Jabr R, El Atrouni W, Shune L, Telfah M, Gao G, He J, Abhyankar S, McGuirk J, Clough L. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Transplant Cell Ther 2021;27:176.e1-8. [PMID: 33830032 DOI: 10.1016/j.jtct.2020.10.009] [Reference Citation Analysis]
145 Thangavelu G, Blazar BR. Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease. Front Immunol 2019;10:309. [PMID: 30906290 DOI: 10.3389/fimmu.2019.00309] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
146 Wang C, Li Q, Li J. Gut microbiota and its implications in small bowel transplantation. Front Med 2018;12:239-48. [PMID: 29524068 DOI: 10.1007/s11684-018-0617-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
147 Lee SE, Lim JY, Ryu DB, Kim TW, Park SS, Jeon YW, Yoon JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Kim CS, Shin DM, Min CK. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant 2019;25:1933-43. [PMID: 31195137 DOI: 10.1016/j.bbmt.2019.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
148 Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T. Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2302-9. [PMID: 29909153 DOI: 10.1016/j.bbmt.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
149 Jensen BAH, Holm JB, Larsen IS, von Burg N, Derer S, Sonne SB, Pærregaard SI, Damgaard MV, Indrelid SA, Rivollier A, Agrinier AL, Sulek K, Arnoldussen YJ, Fjære E, Marette A, Angell IL, Rudi K, Treebak JT, Madsen L, Åkesson CP, Agace W, Sina C, Kleiveland CR, Kristiansen K, Lea TE. Lysates of Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt+IL-17+ Tregs and improve metabolism. Nat Commun 2021;12:1093. [PMID: 33597537 DOI: 10.1038/s41467-021-21408-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
150 Daguindau E, Gautier T, Chagué C, Pais de Barros JP, Deckert V, Lagrost L, Saas P. Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease? Front Immunol 2017;8:952. [PMID: 28848554 DOI: 10.3389/fimmu.2017.00952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
151 Benoit SW, Goldstein SL, Dahale DS, Haslam DB, Nelson A, Truono K, Davies SM. Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients. Biol Blood Marrow Transplant 2019;25:1654-8. [PMID: 31048085 DOI: 10.1016/j.bbmt.2019.04.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
152 Galloway-Peña J, Brumlow C, Shelburne S. Impact of the Microbiota on Bacterial Infections during Cancer Treatment. Trends Microbiol 2017;25:992-1004. [PMID: 28728967 DOI: 10.1016/j.tim.2017.06.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
153 Turner G, Smith M, Hoeschen AL, Wilson JA, Kennedy J, Abramson M, Cao Q, El Jurdi N, MacMillan ML, Weisdorf DJ, Blazar BR, Khoruts A, Shields-Cutler RR, Knights D, Holtan SG, Rashidi A. Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft-versus-host disease: An exploratory analysis. Br J Haematol 2021;192:e69-73. [PMID: 33222185 DOI: 10.1111/bjh.17238] [Reference Citation Analysis]
154 Koyama M, Mukhopadhyay P, Schuster IS, Henden AS, Hülsdünker J, Varelias A, Vetizou M, Kuns RD, Robb RJ, Zhang P, Blazar BR, Thomas R, Begun J, Waddell N, Trinchieri G, Zeiser R, Clouston AD, Degli-Esposti MA, Hill GR. MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. Immunity 2019;51:885-898.e7. [PMID: 31542340 DOI: 10.1016/j.immuni.2019.08.011] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 19.0] [Reference Citation Analysis]
155 Gijsen M, Maertens J, Lagrou K, Peetermans WE, Fage D, Debaveye Y, Spriet I. Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood sampling. Clin Chim Acta 2020;510:450-4. [PMID: 32795542 DOI: 10.1016/j.cca.2020.08.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
157 Pettigrew MM, Gent JF, Kong Y, Halpin AL, Pineles L, Harris AD, Johnson JK. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Clin Infect Dis 2019;69:604-13. [PMID: 30383203 DOI: 10.1093/cid/ciy936] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
158 Sofi MH, Wu Y, Ticer T, Schutt S, Bastian D, Choi HJ, Tian L, Mealer C, Liu C, Westwater C, Armeson KE, Alekseyenko AV, Yu XZ. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight 2021;6:136841. [PMID: 33554953 DOI: 10.1172/jci.insight.136841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
159 Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Woo Ahn K, Komanduri K, Lindemans C, Auletta JJ, Riches ML; CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Clin Infect Dis 2019;69:1771-9. [PMID: 30649224 DOI: 10.1093/cid/ciz031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
160 Vehreschild MJGT, Ducher A, Louie T, Cornely OA, Feger C, Dane A, Varastet M, Vitry F, de Gunzburg J, Andremont A, Mentré F, Wilcox MH. An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones. J Antimicrob Chemother 2022:dkab474. [PMID: 35016205 DOI: 10.1093/jac/dkab474] [Reference Citation Analysis]
161 Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Julamanee J, Takagi E, Hirano D, Miyao K, Sakemura R, Goto T, Hayakawa F, Seto A, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H. High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype. PLoS One 2017;12:e0185213. [PMID: 28945764 DOI: 10.1371/journal.pone.0185213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
162 Ardura MI. Overview of Infections Complicating Pediatric Hematopoietic Cell Transplantation. Infect Dis Clin North Am 2018;32:237-52. [PMID: 29406976 DOI: 10.1016/j.idc.2017.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
163 Osman AEG, Luke JJ. The Impact of the Fecal Microbiome on Cancer Immunotherapy. BioDrugs 2019;33:1-7. [PMID: 30604388 DOI: 10.1007/s40259-018-0328-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
164 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 2018;24:1322-40. [PMID: 29471034 DOI: 10.1016/j.bbmt.2018.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
166 Malard F, Gasc C, Plantamura E, Doré J. High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients. Bone Marrow Transplant 2018;53:1493-7. [PMID: 29904128 DOI: 10.1038/s41409-018-0254-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
167 Camargo JF, Anderson AD, Natori Y, Natori A, Morris MI, Pereira D, Komanduri KV. Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation. Blood Adv 2020;4:6364-7. [PMID: 33351132 DOI: 10.1182/bloodadvances.2020003277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
168 Zama D, Bossù G, Leardini D, Muratore E, Biagi E, Prete A, Pession A, Masetti R. Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation. Ther Adv Hematol 2020;11:2040620719896961. [PMID: 32010434 DOI: 10.1177/2040620719896961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
169 Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol 2017;35:1650-9. [PMID: 28296584 DOI: 10.1200/JCO.2016.70.3348] [Cited by in Crossref: 141] [Cited by in F6Publishing: 92] [Article Influence: 28.2] [Reference Citation Analysis]
170 Stohs E, Chow VA, Liu C, Bourassa L, Miles-Jay A, Knight J, Sweet A, Storer BE, Mielcarek M, Pergam SA. Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease. Biol Blood Marrow Transplant 2019;25:1247-52. [PMID: 30711778 DOI: 10.1016/j.bbmt.2019.01.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
171 Ichinohe T, Miyama T, Kawase T, Honjo Y, Kitaura K, Sato H, Shin-I T, Suzuki R. Next-Generation Immune Repertoire Sequencing as a Clue to Elucidate the Landscape of Immune Modulation by Host-Gut Microbiome Interactions. Front Immunol 2018;9:668. [PMID: 29666626 DOI: 10.3389/fimmu.2018.00668] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
172 Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 2020;26:1738-46. [PMID: 32447043 DOI: 10.1016/j.bbmt.2020.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
173 Murthy HS, Gharaibeh RZ, Al-Mansour Z, Kozlov A, Trikha G, Newsome RC, Gauthier J, Farhadfar N, Wang Y, Kelly DL, Lybarger J, Jobin C, Wang GP, Wingard JR. Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2001-10. [PMID: 32717434 DOI: 10.1016/j.bbmt.2020.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer 2019;66:e27978. [PMID: 31486593 DOI: 10.1002/pbc.27978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
175 Dandoy CE, Alonso PB. MBI-LCBI and CLABSI: more than scrubbing the line. Bone Marrow Transplant 2019;54:1932-9. [PMID: 30809036 DOI: 10.1038/s41409-019-0489-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
176 Bansal R, Park H, Taborda CC, Gordillo C, Mapara MY, Assal A, Uhlemann AC, Reshef R. Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation: Antibiotics in auto and allo transplant. Transplant Cell Ther 2021:S2666-6367(21)01448-2. [PMID: 34958974 DOI: 10.1016/j.jtct.2021.12.015] [Reference Citation Analysis]
177 Ustun C, Young JH, Papanicolaou GA, Kim S, Ahn KW, Chen M, Abdel-Azim H, Aljurf M, Beitinjaneh A, Brown V, Cerny J, Chhabra S, Kharfan-Dabaja MA, Dahi PB, Daly A, Dandoy CE, Dvorak CC, Freytes CO, Hashmi S, Lazarus H, Ljungman P, Nishihori T, Page K, Pingali SRK, Saad A, Savani BN, Weisdorf D, Williams K, Wirk B, Auletta JJ, Lindemans CA, Komanduri K, Riches M. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2019;54:1254-65. [PMID: 30546070 DOI: 10.1038/s41409-018-0401-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
178 Ma J, Zhu W, Liu B. Role of gut microbiome in the outcome of cancer immunotherapy. Int J Cancer 2021. [PMID: 33600603 DOI: 10.1002/ijc.33524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
179 Wardill HR, de Mooij CEM, da Silva Ferreira AR, van de Peppel IP, Havinga R, Harmsen HJM, Tissing WJE, Blijlevens NMA. Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever. Cancer Chemother Pharmacol 2021;88:173-88. [PMID: 33877390 DOI: 10.1007/s00280-021-04273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
180 Rashidi A, Kaiser T, Graiziger C, Holtan SG, Rehman TU, Weisdorf DJ, Dunny GM, Khoruts A, Staley C. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation. Cancer 2020;126:1434-47. [PMID: 31873965 DOI: 10.1002/cncr.32641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
181 Elgarten CW, Li Y, Getz KD, Hemmer M, Huang YV, Hall M, Wang T, Kitko CL, Jagasia MH, Nishihori T, Murthy HS, Hashem H, Cairo MS, Sharma A, Hashmi SK, Askar M, Beitinjaneh A, Kelly MS, Auletta JJ, Badawy SM, Mavers M, Aplenc R, MacMillan ML, Spellman SR, Arora M, Fisher BT. Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease. Transplant Cell Ther 2021;27:177.e1-8. [PMID: 33718896 DOI: 10.1016/j.jtct.2020.10.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Gałązka P, Styczyński J, Czyżewski K, Salamonowicz-Bodzioch M, Frączkiewicz J, Zając-Spychała O, Zaucha-Prażmo A, Goździk J, Biliński J, Basak GW. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: Decontamination therapy in allo-HCT. Curr Res Transl Med 2021;69:103298. [PMID: 34144374 DOI: 10.1016/j.retram.2021.103298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 McQuade JL, Ologun GO, Arora R, Wargo JA. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. Curr Oncol Rep 2020;22:74. [PMID: 32577835 DOI: 10.1007/s11912-020-00913-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
184 Jansen SA, Nijhuis W, Leavis HL, Riezebos-Brilman A, Lindemans CA, Schuurman R. Broad Virus Detection and Variant Discovery in Fecal Samples of Hematopoietic Transplant Recipients Using Targeted Sequence Capture Metagenomics. Front Microbiol 2020;11:560179. [PMID: 33281758 DOI: 10.3389/fmicb.2020.560179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 Koh AY. The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection. PLoS Pathog 2017;13:e1006342. [PMID: 28662165 DOI: 10.1371/journal.ppat.1006342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
186 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
187 Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson JC, Bohannon L, Martin PL, Stokhuyzen A, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Arshad M, Seed PC, Kelly MS. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2053-60. [PMID: 32682948 DOI: 10.1016/j.bbmt.2020.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
188 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
189 Staffas A, Burgos da Silva M, van den Brink MR. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood 2017;129:927-33. [PMID: 27940475 DOI: 10.1182/blood-2016-09-691394] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 15.8] [Reference Citation Analysis]
190 Kumari R, Palaniyandi S, Hildebrandt GC. The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease. Bone Marrow Transplant 2021;56:1777-83. [PMID: 34052837 DOI: 10.1038/s41409-021-01325-7] [Reference Citation Analysis]
191 Shouval R, Geva M, Nagler A, Youngster I. Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease. Clin Hematol Int 2019;1:28-35. [PMID: 34595408 DOI: 10.2991/chi.d.190316.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
192 Ingham AC, Kielsen K, Mordhorst H, Ifversen M, Aarestrup FM, Müller KG, Pamp SJ. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome 2021;9:148. [PMID: 34183060 DOI: 10.1186/s40168-021-01100-2] [Reference Citation Analysis]
193 Shah NN, Parta M, Baird K, Rafei H, Cole K, Holland SM, Hickstein DD. Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD. Bone Marrow Transplant 2017;52:1580-2. [PMID: 28825694 DOI: 10.1038/bmt.2017.180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
194 Sexton ME, Langston AA, Wiley Z, Nowak MD, Jacob JT. Antimicrobial Stewardship in the Hematopoietic Stem Cell Transplant Population. Curr Treat Options Infect Dis 2018;10:249-62. [DOI: 10.1007/s40506-018-0159-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 2017 NIH-wide microbiome workshop writing team. 2017 NIH-wide workshop report on "The Human Microbiome: Emerging Themes at the Horizon of the 21st Century". Microbiome 2019;7:32. [PMID: 30808401 DOI: 10.1186/s40168-019-0627-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
196 O'Dwyer DN, Zhou X, Wilke CA, Xia M, Falkowski NR, Norman KC, Arnold KB, Huffnagle GB, Murray S, Erb-Downward JR, Yanik GA, Moore BB, Dickson RP. Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation. Am J Respir Crit Care Med 2018;198:1312-21. [PMID: 29878854 DOI: 10.1164/rccm.201712-2456OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
197 Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ; CDC Prevention Epicenters Program. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy. Open Forum Infect Dis 2019;6:ofz252. [PMID: 31281857 DOI: 10.1093/ofid/ofz252] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
198 Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol 2020;27:360-7. [PMID: 33003084 DOI: 10.1097/MOH.0000000000000616] [Reference Citation Analysis]
199 Mengwasser J, Babes L, Cordes S, Mertlitz S, Riesner K, Shi Y, McGearey A, Kalupa M, Reinheckel T, Penack O. Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility. Front Immunol 2017;8:203. [PMID: 28298913 DOI: 10.3389/fimmu.2017.00203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
200 Holler E, Weber D. Fit for cure? Microbiota and GVHD. Blood 2016;128:2004-5. [PMID: 28157678 DOI: 10.1182/blood-2016-08-732156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
201 Khan MAW, Ologun G, Arora R, McQuade JL, Wargo JA. Gut Microbiome Modulates Response to Cancer Immunotherapy. Dig Dis Sci 2020;65:885-96. [PMID: 32067144 DOI: 10.1007/s10620-020-06111-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
202 Farowski F, Bücker V, Vehreschild JJ, Biehl L, Cruz-Aguilar R, Scheid C, Holtick U, Jazmati N, Wisplinghoff H, Cornely OA, Vehreschild MJGT. Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2018;53:52-7. [PMID: 29131156 DOI: 10.1038/bmt.2017.203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
203 Smibert OC, Trubiano JA, Slavin MA, Kwong JC. An infectious diseases perspective on the microbiome and allogeneic stem cell transplant. Curr Opin Infect Dis 2020;33:426-32. [PMID: 33148984 DOI: 10.1097/QCO.0000000000000683] [Reference Citation Analysis]
204 Rattanathammethee T, Tuitemwong P, Thiennimitr P, Sarichai P, Na Pombejra S, Piriyakhuntorn P, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Tantiworawit A, Norasetthada L. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS One 2020;15:e0236460. [PMID: 33112882 DOI: 10.1371/journal.pone.0236460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Lee MW, Yeon SH, Heo BY, Kwon J, Ryu H, Lee HJ, Yun HJ, Jo DY, Song IC. Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Hematology 2021;26:96-102. [PMID: 33459581 DOI: 10.1080/16078454.2021.1872957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18:283-95. [PMID: 29449660 DOI: 10.1038/nrc.2018.10] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 22.0] [Reference Citation Analysis]
207 Murphy CL, OʼToole PW, Shanahan F. The Gut Microbiota in Causation, Detection, and Treatment of Cancer. Am J Gastroenterol 2019;114:1036-42. [PMID: 30848738 DOI: 10.14309/ajg.0000000000000075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
208 Sano H, Hilinski JA, Qayed M, Applegate K, Newton JG, Watkins B, Chiang KY, Horan J. Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents. Pediatr Blood Cancer 2018;65. [PMID: 28921804 DOI: 10.1002/pbc.26821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
209 Han L, Zhang H, Ma P, Peng J, Li Y, Wu J, Li Y, Yu J, Li W, Zhang M, He JB, Fan Z, Wang W, Sang L, Sun H, Liu Q, Liu Y, Jiang Z. Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation. Ann Hematol 2022. [PMID: 35332375 DOI: 10.1007/s00277-022-04817-8] [Reference Citation Analysis]
210 Atilla E, Atilla PA, Bozdağ SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection 2017;45:403-11. [PMID: 28417421 DOI: 10.1007/s15010-017-1016-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
211 Makris S, de Winde CM, Horsnell HL, Cantoral-rebordinos JA, Finlay RE, Acton SE. Immune function and dysfunction are determined by lymphoid tissue efficacy. Disease Models & Mechanisms 2022;15:dmm049256. [DOI: 10.1242/dmm.049256] [Reference Citation Analysis]
212 Liao C, Taylor BP, Ceccarani C, Fontana E, Amoretti LA, Wright RJ, Gomes ALC, Peled JU, Taur Y, Perales MA, van den Brink MRM, Littmann E, Pamer EG, Schluter J, Xavier JB. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data 2021;8:71. [PMID: 33654104 DOI: 10.1038/s41597-021-00860-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
213 Rashidi A, Kaiser T, Holtan SG, Rehman TU, Weisdorf DJ, Khoruts A, Staley C. Levaquin Gets a Pass. Biol Blood Marrow Transplant 2020;26:778-81. [PMID: 31870930 DOI: 10.1016/j.bbmt.2019.12.722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Shono Y, van den Brink MRM. Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? Blood Adv 2017;1:2325-8. [PMID: 29296882 DOI: 10.1182/bloodadvances.2017005108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
215 Clemmons AB, Gandhi AS, Albrecht B, Jacobson S, Pantin J. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation. J Oncol Pharm Pract 2019;25:326-32. [PMID: 29059026 DOI: 10.1177/1078155217735153] [Reference Citation Analysis]
216 Riwes M, Reddy P. Microbial metabolites and graft versus host disease. Am J Transplant 2018;18:23-9. [PMID: 28742948 DOI: 10.1111/ajt.14443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
217 Biernat MM, Urbaniak-Kujda D, Dybko J, Kapelko-Słowik K, Prajs I, Wróbel T. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. J Int Med Res 2020;48:300060520925693. [PMID: 32527171 DOI: 10.1177/0300060520925693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
218 Markey KA, Schluter J, Gomes ALC, Littmann ER, Pickard AJ, Taylor BP, Giardina PA, Weber D, Dai A, Docampo MD, Armijo GK, Slingerland AE, Slingerland JB, Nichols KB, Brereton DG, Clurman AG, Ramos RJ, Rao A, Bush A, Bohannon L, Covington M, Lew MV, Rizzieri DA, Chao N, Maloy M, Cho C, Politikos I, Giralt S, Taur Y, Pamer EG, Holler E, Perales MA, Ponce DM, Devlin SM, Xavier J, Sung AD, Peled JU, Cross JR, van den Brink MRM. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood 2020;136:130-6. [PMID: 32430495 DOI: 10.1182/blood.2019003369] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 29.0] [Reference Citation Analysis]
219 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
220 Holtan SG, Versluis J, Weisdorf DJ, Cornelissen JJ. Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. J Clin Oncol 2021;39:373-85. [PMID: 33434075 DOI: 10.1200/JCO.20.01771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
221 Theilgaard-mönch K. Gut microbiota sustains hematopoiesis. Blood 2017;129:662-3. [DOI: 10.1182/blood-2016-12-754481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
222 Giaccone L, Faraci DG, Butera S, Lia G, Di Vito C, Gabrielli G, Cerrano M, Mariotti J, Dellacasa C, Felicetti F, Brignardello E, Mavilio D, Bruno B. Biomarkers for acute and chronic graft versus host disease: state of the art. Expert Rev Hematol 2021;14:79-96. [PMID: 33297779 DOI: 10.1080/17474086.2021.1860001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Messaoudene M, Derosa L, Belkaid W, Routy B. [In bacteria veritas: pronostic role of intestinal microbiote in cancer therapy]. Med Sci (Paris) 2018;34:657-9. [PMID: 30230457 DOI: 10.1051/medsci/20183408009] [Reference Citation Analysis]
224 Larsen IS, Jensen BAH, Bonazzi E, Choi BSY, Kristensen NN, Schmidt EGW, Süenderhauf A, Morin L, Olsen PB, Hansen LBS, Schröder T, Sina C, Chassaing B, Marette A. Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis. Gut Microbes 2021;13:1988836. [PMID: 34693864 DOI: 10.1080/19490976.2021.1988836] [Reference Citation Analysis]
225 Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S. [Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2019;106:S23-34. [PMID: 30616839 DOI: 10.1016/j.bulcan.2018.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
226 Vaughn BP, Rank KM, Khoruts A. Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease. Clin Gastroenterol Hepatol. 2019;17:353-361. [PMID: 30055267 DOI: 10.1016/j.cgh.2018.07.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
227 Weber D, Hiergeist A, Weber M, Dettmer K, Wolff D, Hahn J, Herr W, Gessner A, Holler E. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics. Clin Infect Dis 2019;68:1303-10. [PMID: 30124813 DOI: 10.1093/cid/ciy711] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
228 Koh AY. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. Clin Chem 2017;63:1685-94. [PMID: 28720679 DOI: 10.1373/clinchem.2016.259499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
229 Lind ML, Phipps AI, Mooney S, Liu C, Fohner A, Patel K, Ueda M, Pergam SA. Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections. Clin Infect Dis 2021;72:1220-9. [PMID: 32133490 DOI: 10.1093/cid/ciaa214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
230 Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, Silva CAC, Terrisse S, Bonvalet M, Scherpereel A, Pegliasco H, Richard C, Ghiringhelli F, Elkrief A, Desilets A, Blanc-Durand F, Cumbo F, Blanco A, Boidot R, Chevrier S, Daillère R, Kroemer G, Alla L, Pons N, Le Chatelier E, Galleron N, Roume H, Dubuisson A, Bouchard N, Messaoudene M, Drubay D, Deutsch E, Barlesi F, Planchard D, Segata N, Martinez S, Zitvogel L, Soria JC, Besse B. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med 2022. [PMID: 35115705 DOI: 10.1038/s41591-021-01655-5] [Reference Citation Analysis]
231 Goeser F, Sifft B, Stein-Thoeringer C, Farowski F, Strassburg CP, Brossart P, Higgins PG, Scheid C, Wolf D, Holderried TAW, Vehreschild MJGT, Cruz Aguilar MR. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers. Eur J Haematol 2021;107:229-45. [PMID: 33934412 DOI: 10.1111/ejh.13642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Ferreira FM, Palle P, Vom Berg J, Prajwal P, Laman JD, Buch T. Bone marrow chimeras-a vital tool in basic and translational research. J Mol Med (Berl) 2019;97:889-96. [PMID: 31028417 DOI: 10.1007/s00109-019-01783-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
233 Costantini C, Nunzi E, Spolzino A, Palmieri M, Renga G, Zelante T, Englmaier L, Coufalikova K, Spáčil Z, Borghi M, Bellet MM, Acerbi E, Puccetti M, Giovagnoli S, Spaccapelo R, Talesa VN, Lomurno G, Merli F, Facchini L, Spadea A, Melillo L, Codeluppi K, Marchesi F, Marchesini G, Valente D, Dragonetti G, Nadali G, Pagano L, Aversa F, Romani L. Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients. Infect Immun 2021;89:e0010521. [PMID: 33782152 DOI: 10.1128/IAI.00105-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
234 Jahan D, Peile E, Sheikh MA, Islam S, Parasnath S, Sharma P, Iskandar K, Dhingra S, Charan J, Hardcastle TC, Samad N, Chowdhury TS, Dutta S, Haque M. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation. Expert Rev Anti Infect Ther 2021;:1-22. [PMID: 33711240 DOI: 10.1080/14787210.2021.1902304] [Reference Citation Analysis]
235 Daoud-Asfour H, Henig I, Ghersin I, Rakedzon S, Stern A, Pitashny M, Zuckerman T, Bar-Yoseph H. Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure. Transplant Cell Ther 2021:S2666-6367(21)01445-7. [PMID: 34954293 DOI: 10.1016/j.jtct.2021.12.012] [Reference Citation Analysis]
236 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Hematology Am Soc Hematol Educ Program 2016;2016:119-27. [PMID: 27913470 DOI: 10.1182/asheducation-2016.1.119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
237 Zeiser R, Blazar BR. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017;377:2167-2179. [PMID: 29171820 DOI: 10.1056/nejmra1609337] [Cited by in Crossref: 369] [Cited by in F6Publishing: 238] [Article Influence: 73.8] [Reference Citation Analysis]
238 MacDonald KP, Hill GR, Blazar BR. Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood 2017;129:13-21. [PMID: 27821504 DOI: 10.1182/blood-2016-06-686618] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 21.2] [Reference Citation Analysis]
239 Hermann A, Winkler A, Paschen C, Kuzmina Z, Hladik A, Icme S, Robak O. Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Exp Hematol 2019;74:25-32.e1. [PMID: 31078634 DOI: 10.1016/j.exphem.2019.05.001] [Reference Citation Analysis]
240 Masetti R, Muratore E, Leardini D, Zama D, Turroni S, Brigidi P, Esposito S, Pession A. Gut microbiome in pediatric acute leukemia: from predisposition to cure. Blood Adv 2021;5:4619-29. [PMID: 34610115 DOI: 10.1182/bloodadvances.2021005129] [Reference Citation Analysis]
241 Pereira AZ, Vigorito AC, Almeida AM, Candolo AA, Silva ACL, Brandão-Anjos AEP, Sá BL, Souza CLS, Castro Junior CG, Oliveira JSR, Barban JB, Mancilha EMB, Todaro J, Lopes LP, Macedo MCMA, Rodrigues M, Ribeiro PC, Silva RLD, Roberto TS, Rodrigues TCR, Colturato VAR, Paton EJA, Barros GMN, Almeida RDS, Moreira MCR, Flowers ME. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease. Einstein (Sao Paulo) 2020;18:eAE4799. [PMID: 32215466 DOI: 10.31744/einstein_journal/2020AE4799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Davidovics ZH, Michail S, Nicholson MR, Kociolek LK, Pai N, Hansen R, Schwerd T, Maspons A, Shamir R, Szajewska H, Thapar N, de Meij T, Mosca A, Vandenplas Y, Kahn SA, Kellermayer R; FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology Hepatology, Nutrition. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;68:130-43. [PMID: 30540704 DOI: 10.1097/MPG.0000000000002205] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 21.5] [Reference Citation Analysis]
244 Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Ann Oncol 2019;30:1572-9. [PMID: 31268133 DOI: 10.1093/annonc/mdz206] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 28.0] [Reference Citation Analysis]
245 Hu L, Wang Q, Zhang X, Xu L, Wang Y, Yan C, Chen H, Chen Y, Liu K, Wang H, Huang X, Mo X. Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation. Front Med 2019;13:492-503. [PMID: 30953261 DOI: 10.1007/s11684-019-0681-0] [Reference Citation Analysis]
246 Zhang J, Ren G, Li M, Lu P, Yi S. The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation. Case Rep Hematol 2019;2019:4505238. [PMID: 31049232 DOI: 10.1155/2019/4505238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
247 Hill L, Alousi A, Kebriaei P, Mehta R, Rezvani K, Shpall E. New and emerging therapies for acute and chronic graft versus host disease. Ther Adv Hematol. 2018;9:21-46. [PMID: 29317998 DOI: 10.1177/2040620717741860] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
248 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
249 Ziegler M, Landsburg D, Pegues D, Bilker W, Gilmar C, Kucharczuk C, Gorman T, Bink K, Moore A, Fitzpatrick R, Stadtmauer EA, Mangan P, Kraus K, Han JH. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients. Biol Blood Marrow Transplant 2019;25:1004-10. [PMID: 30481595 DOI: 10.1016/j.bbmt.2018.11.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
250 de Koning C, Nierkens S, Boelens JJ. Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution. Blood 2016;128:2607-15. [PMID: 27697775 DOI: 10.1182/blood-2016-06-724005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
251 Ferrara JLM, Chaudhry MS. GVHD: biology matters. Blood Adv 2018;2:3411-7. [PMID: 30482771 DOI: 10.1182/bloodadvances.2018020214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
252 Elgarten CW, Tanes C, Lee JJ, Danziger-Isakov LA, Grimley MS, Green M, Michaels MG, Barnum JL, Ardura MI, Auletta JJ, Blumenstock J, Seif AE, Bittinger KL, Fisher BT. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 2021;:e29384. [PMID: 34709713 DOI: 10.1002/pbc.29384] [Reference Citation Analysis]
253 Satwani P, Freedman JL, Chaudhury S, Jin Z, Levinson A, Foca MD, Krajewski J, Sahdev I, Talekar MK, Gardenswartz A, Silverman J, Hayes M, Dvorak CC. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 2017;23:642-7. [DOI: 10.1016/j.bbmt.2017.01.073] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
254 McQuade JL, Daniel CR, Helmink BA, Wargo JA. Modulating the microbiome to improve therapeutic response in cancer. Lancet Oncol 2019;20:e77-91. [PMID: 30712808 DOI: 10.1016/S1470-2045(18)30952-5] [Cited by in Crossref: 108] [Cited by in F6Publishing: 56] [Article Influence: 54.0] [Reference Citation Analysis]
255 Chong PP, Koh AY. The gut microbiota in transplant patients. Blood Rev 2020;39:100614. [PMID: 31492463 DOI: 10.1016/j.blre.2019.100614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
256 Naymagon S, Naymagon L, Wong SY, Ko HM, Renteria A, Levine J, Colombel JF, Ferrara J. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol. 2017;14:711-726. [PMID: 28951581 DOI: 10.1038/nrgastro.2017.126] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
257 Ma T, Chen Y, Li LJ, Zhang LS. Opportunities and Challenges for Gut Microbiota in Acute Leukemia. Front Oncol 2021;11:692951. [PMID: 34307157 DOI: 10.3389/fonc.2021.692951] [Reference Citation Analysis]
258 Clemmons AB, Bech CF, Pantin J, Ahmad I. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime. Biology of Blood and Marrow Transplantation 2018;24:820-6. [DOI: 10.1016/j.bbmt.2017.12.799] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
259 Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell 2021;39:1317-41. [PMID: 34506740 DOI: 10.1016/j.ccell.2021.08.006] [Reference Citation Analysis]